Table 2 Quality assessment using New Castel Ottawa Scale.
From: Immune Persistence After Infant Hepatitis-B Vaccination: A Systematic Review and Meta-Analysis
Authors/reference | Selection | Comparability | Outcomes | Total Score | |||||
|---|---|---|---|---|---|---|---|---|---|
Representative of Exposed Cohort | Selection of Non-Exposed Cohort | Ascertainment of Exposure | Outcomes not Present at Baseline | Assessment of Outcomes | Sufficient Follow up Duration | Adequate Follow up | |||
Bruce et al. | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 8 |
Wu et al. | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
Poovorawan et al. | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 8 |
Al-Ghamdi et al. | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
Su et al. | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
Al Faleh et al. | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
Spada et al. | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 8 |
Middleman et al. | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 8 |
Avidoca et al. | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 8 |
Gold et al. | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 8 |
Tsega et al. | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
Amini et al. | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 7 |
